DalsnaFinance

Wells Fargo raises Amgen stock price target to $435 on drug trial outlook

Stocks Investing.com India By Investing.com India 04 Sep 2026 10:25 1 min read
Wells Fargo raises Amgen stock price target to $435 on drug trial outlook

Wells Fargo raises Amgen stock price target to $435 on drug trial outlook  Investing.com India

Covered in this story

Amgen AMGN Target Corporation TGT Wells Fargo WFC
Read the full story on Investing.com India → Opens the original article on news.google.com

Summary aggregated from Investing.com India's public RSS feed. The full reporting belongs to Investing.com India — please read it on their site.